Anke Post

Company: AC Immune SA

Job title: Chief Medical Officer

Seminars:

Evaluating the Diagnostic Activity of TDP-43 PET Tracer in FTD & ALS for Earlier Diagnosis & Treatment in Humans 11:00 am

Discovery and characterization of the first in class TDP-43 PET tracer sensitivity Delving into the preclinical characterization of ACI-19626 to correlate TDP-43 pathology with disease progression Clinical trial design Exploring early clinical data to show temporal TDP-43 aggregate change with longitudinal disease progression in humans, for improved disease staging in a heterogenous ALS population Understanding…Read more

day: Conference Day One Track B